Candice Cameron, PA
Physician Assistant · Reno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Community Care Services LLC · 630 clinicians in this group
Hospitals listed: Renown Regional Medical Center · Renown South Meadows Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Candice Cameron’s office at (775) 982-7878 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Renown Regional Medical CenterReno, NVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Renown Health, which runs 3 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 231.33 (200.05 to 262.61) · 302 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.14 (0 to 0.56) · 11,907 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.438, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.208, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.636, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.344, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 7.9 (6.3 to 9.9) · 547 cases, Jan 2024 – Dec 2024
- Renown South Meadows Medical CenterReno, NVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Renown Health, which runs 3 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Renown Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 231.33 (200.05 to 262.61) · 302 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.56) · 11,907 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.438 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.208 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.636 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.344 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (6.3 to 9.9) · 547 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.36 to 1.92) · 3,106 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.81 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 592 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 734 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 585 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 683 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 6,021 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.11 to 0.44) · 14,463 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.16 to 0.5) · 14,984 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.71 (3.29 to 6.12) · 4,503 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.62 (1.22 to 4.02) · 1,605 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.24 (2.11 to 4.36) · 4,125 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.78 (7 to 16.56) · 1,560 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (2.2 to 8.2) · 1,551 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.53 (0.22 to 2.83) · 1,024 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.531 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.725 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.9 · 668 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,041 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -11.3 · 643 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.6 · 850 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.5 · 631 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 776 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.6 to 6.5) · 547 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 354 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 18.1) · 50 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.3) · 948 cases | No different | Jan 2024 – Dec 2024 |
What patients said (849 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Renown South Meadows Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2) · 468 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.53 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.34 (118.85 to 241.84) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 59 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 167 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 240 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 43 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,426 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,825 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,869 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.57 (1.22 to 5.91) · 595 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.08 (0.37 to 3.79) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.17 (0.5 to 3.84) · 527 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (1.1 to 19.11) · 232 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.59 (1.47 to 9.7) · 177 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.21) · 128 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,895 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 50 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.6 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.054 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.6 · 185 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 259 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 303 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.1 to 8.1) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (7.7 to 16.7) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 18) · 92 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 676 cases | No different | Jan 2024 – Dec 2024 |
What patients said (499 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$32,225
Medicare paid this office $32,225 for 201 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 121 | $11,574 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $4,298 | $107 |
| Short return visit (20+ min) | 64 | $4,110 | $49 |
| Influenza vaccine split virus, preservative free | 20 | $1,614 | $81 |
| New patient visit (45+ min) | 14 | $1,105 | $79 |
See all 6 services
| Return visit (30+ min) | 121 | $11,574 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $4,298 | $107 |
| Short return visit (20+ min) | 64 | $4,110 | $49 |
| Influenza vaccine split virus, preservative free | 20 | $1,614 | $81 |
| New patient visit (45+ min) | 14 | $1,105 | $79 |
| Administration of influenza virus vaccine | 22 | $698 | $32 |
Who their Medicare patients are
201 Original Medicare patients in 2024. Average age 74 · Women 64% · Also on Medicaid 6% · Health risk score 0.89. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 57% · Coronary heart disease 18% · Diabetes 16% · Depression 15% · Chronic kidney disease 13% · Cancer 13% · Atrial fibrillation 10% · COPD 8% · Heart failure 7%.
The office billed $125,459, Medicare allowed $43,980 and paid $32,225; for 463 services of 29 kinds; $4,854 of it was for drugs given in the office and $27,370 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 201 | 463 | 74 | 0.89 | $125,459 | $32,225 |
| 2023 | 233 | 579 | 74 | 0.92 | $135,596 | $42,667 |
| 2022 | 268 | 517 | 73 | 0.93 | $112,396 | $33,395 |
| 2021 | 48 | 74 | 73 | 0.97 | $12,864 | $4,733 |
| 2020 | 189 | 966 | 74 | 1.16 | $64,892 | $17,862 |
| 2019 | 478 | 5,309 | 75 | 1.45 | $223,437 | $68,833 |
| 2018 | 451 | 2,074 | 75 | 1.32 | $152,203 | $44,853 |
| 2017 | 295 | 893 | 75 | 1.29 | $75,789 | $23,601 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 127 | $13,694 | $70 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 28 | $7,902 | $282 |
| Short return visit (20+ min) | 95 | $6,068 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 48 | $5,341 | $111 |
| Influenza vaccine split virus, preservative free | 30 | $2,158 | $72 |
| New patient visit (45+ min) | 13 | $1,143 | $88 |
| Administration of influenza virus vaccine | 30 | $800 | $27 |
| Administration of pneumococcal vaccine | 28 | $746 | $27 |
| New patient visit (30+ min) | 13 | $541 | $42 |
2022: 8 services
| Return visit (30+ min) | 119 | $11,149 | $73 |
| Short return visit (20+ min) | 146 | $9,635 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $2,518 | $114 |
| New patient visit (45+ min) | 21 | $2,275 | $108 |
| Influenza vaccine split virus, preservative free | 21 | $1,368 | $65 |
| Short return visit | 18 | $717 | $40 |
| Administration of influenza virus vaccine | 23 | $568 | $25 |
| Urinalysis, manual test | 15 | $51 | $3 |
2021: 1 service
| Short return visit (20+ min) | 30 | $2,243 | $70 |
2020: 11 services
| Short return visit (20+ min) | 109 | $3,081 | $24 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $2,709 | $93 |
| Return visit (30+ min) | 50 | $2,612 | $47 |
| Blood test, comprehensive group of blood chemicals | 35 | $366 | $10 |
| Blood test, thyroid stimulating hormone (tsh) | 21 | $348 | $17 |
| Blood test, lipids (cholesterol and triglycerides) | 22 | $291 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 34 | $261 | $8 |
| Insertion of needle into vein for collection of blood sample | 45 | $145 | $3 |
| Hemoglobin a1c level | 11 | $105 | $10 |
| Injection of drug or substance under skin or into muscle | 22 | $92 | $4 |
| Manual urinalysis test with examination using microscope, automated | 17 | $53 | $3 |
2019: 22 services
| Short return visit (20+ min) | 307 | $16,805 | $39 |
| Return visit (30+ min) | 165 | $12,911 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 119 | $10,966 | $92 |
| Influenza vaccine, inactivated | 34 | $1,974 | $58 |
| Blood test, thyroid stimulating hormone (tsh) | 58 | $1,226 | $18 |
| Blood test, comprehensive group of blood chemicals | 83 | $1,093 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 53 | $860 | $15 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 88 | $854 | $8 |
| Injection of drug or substance under skin or into muscle | 65 | $726 | $9 |
| Administration of influenza virus vaccine | 36 | $549 | $15 |
| Vitamin d-3 level | 13 | $516 | $32 |
| Insertion of needle into vein for collection of blood sample | 126 | $462 | $3 |
| Hemoglobin a1c level | 27 | $370 | $11 |
| X-ray of chest, 2 views | 28 | $368 | $13 |
| Blood test, basic group of blood chemicals (calcium, total) | 34 | $350 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $211 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 27 | $211 | $7 |
| Cyanocobalamin (vitamin b-12) level | 11 | $181 | $16 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 32 | $136 | None |
| Manual urinalysis test with examination using microscope, automated | 37 | $135 | $3 |
| Magnesium level | 12 | $95 | $7 |
| Injection, ketorolac tromethamine, per 15 mg | 24 | $18 | None |
2018: 21 services
| Short return visit (20+ min) | 318 | $14,202 | $36 |
| Return visit (30+ min) | 167 | $12,063 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $3,249 | $93 |
| Blood test, comprehensive group of blood chemicals | 84 | $1,201 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 50 | $1,118 | $20 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 81 | $874 | $9 |
| Influenza vaccine, inactivated | 16 | $857 | $54 |
| Blood test, lipids (cholesterol and triglycerides) | 41 | $745 | $16 |
| Vitamin d-3 level | 13 | $466 | $36 |
| Injection of drug or substance under skin or into muscle | 34 | $367 | $10 |
| Insertion of needle into vein for collection of blood sample | 106 | $356 | $3 |
| Administration of influenza virus vaccine | 19 | $352 | $19 |
| Hemoglobin a1c level | 24 | $282 | $12 |
| Blood test, basic group of blood chemicals (calcium, total) | 14 | $164 | $10 |
| X-ray of chest, 2 views | 14 | $161 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 17 | $149 | $8 |
| Magnesium level | 14 | $130 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $130 | $7 |
| Manual urinalysis test with examination using microscope, automated | 27 | $108 | $4 |
| Injection, ceftriaxone sodium, per 250 mg | 13 | $18 | None |
| Injection, ketorolac tromethamine, per 15 mg | 14 | $9 | None |
2017: 11 services
| Short return visit (20+ min) | 249 | $13,495 | $44 |
| Return visit (30+ min) | 41 | $3,396 | $68 |
| Blood test, comprehensive group of blood chemicals | 51 | $794 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 45 | $523 | $10 |
| Blood test, thyroid stimulating hormone (tsh) | 22 | $497 | $23 |
| Injection of drug or substance under skin or into muscle | 26 | $429 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $243 | $11 |
| Insertion of needle into vein for collection of blood sample | 56 | $200 | $3 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $178 | $15 |
| Manual urinalysis test with examination using microscope, automated | 27 | $128 | $4 |
| Injection, ceftriaxone sodium, per 250 mg | 15 | $30 | None |
Drugs they prescribed that Part D paid
$205,653
Pharmacies billed $205,653 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,316 generic and 275 brand-name prescriptions · $205,653 in drug cost · 59 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 34 | $45,276 | $1,332 |
| Eliquis | 16 | $24,688 | $1,543 |
| Trelegy Ellipta | 16 | $9,348 | $584 |
| Atorvastatin | 176 | $2,889 | $16 |
| Levothyroxine | 152 | $1,871 | $12 |
See all 61 drugs
| Ozempic | 34 | $45,276 | $1,332 |
| Eliquis | 16 | $24,688 | $1,543 |
| Trelegy Ellipta | 16 | $9,348 | $584 |
| Atorvastatin | 176 | $2,889 | $16 |
| Levothyroxine | 152 | $1,871 | $12 |
| Ondansetron | 11 | $1,634 | $149 |
| Metoprolol | 56 | $1,454 | $26 |
| Gabapentin | 52 | $1,434 | $28 |
| Omeprazole | 76 | $1,260 | $17 |
| Albuterol Sulfate Hfa | 37 | $1,248 | $34 |
| Losartan | 73 | $1,224 | $17 |
| Synthroid | 14 | $1,057 | $75 |
| Simvastatin | 88 | $928 | $11 |
| Amlodipine Besylate | 122 | $918 | $8 |
| Rosuvastatin | 42 | $888 | $21 |
| Bupropion Xl | 17 | $864 | $51 |
| Lisinopril | 95 | $790 | $8 |
| Tamsulosin | 35 | $659 | $19 |
| Metformin Hcl Er | 23 | $631 | $27 |
| Pregabalin | 15 | $576 | $38 |
| Ventolin Hfa | 11 | $575 | $52 |
| Valacyclovir | 20 | $570 | $28 |
| Duloxetine | 20 | $560 | $28 |
| Estradiol | 12 | $515 | $43 |
| Pantoprazole | 25 | $511 | $20 |
| Ezetimibe | 15 | $511 | $34 |
| Sertraline | 41 | $502 | $12 |
| Diclofenac | 16 | $501 | $31 |
| Fluoxetine | 23 | $497 | $22 |
| Trazodone | 55 | $482 | $9 |
| Propranolol | 15 | $381 | $25 |
| Hydrochlorothiazide | 60 | $360 | $6 |
| Metformin | 41 | $331 | $8 |
| Potassium Chloride | 15 | $330 | $22 |
| Escitalopram | 21 | $320 | $15 |
| Carvedilol | 13 | $315 | $24 |
| Montelukast | 25 | $311 | $12 |
| Venlafaxine Hcl Er | 12 | $278 | $23 |
| Clopidogrel | 11 | $269 | $24 |
| Pravastatin | 15 | $258 | $17 |
| Losartan-Hydrochlorothiazide | 19 | $255 | $13 |
| Lisinopril-Hydrochlorothiazide | 22 | $251 | $11 |
| Lovastatin | 19 | $233 | $12 |
| Zolpidem | 26 | $229 | $9 |
| Ropinirole | 11 | $214 | $19 |
| Alendronate | 32 | $191 | $6 |
| Fluticasone Propionate | 14 | $174 | $12 |
| Benazepril | 13 | $173 | $13 |
| Allopurinol | 13 | $160 | $12 |
| Ipratropium | 14 | $125 | $9 |
| Methylprednisolone | 27 | $114 | $4 |
| Alprazolam | 28 | $82 | $3 |
| Triamcinolone Acetonide | 22 | $79 | $4 |
| Citalopram Hbr | 14 | $73 | $5 |
| Amoxicillin-Clavulanate Potass | 16 | $70 | $4 |
| Clonazepam | 11 | $67 | $6 |
| Meloxicam | 16 | $41 | $3 |
| Metoprolol | 15 | $40 | $3 |
| Ibuprofen | 12 | $34 | $3 |
| Cyclobenzaprine | 14 | $30 | $2 |
| Promethazine | 11 | $19 | $2 |
Year by year
| 2024 | 2,602 | 529 | None | 11% | $205,653 |
| 2023 | 2,322 | 535 | 1% (17) | None | $176,439 |
| 2022 | 1,699 | 522 | 2% (31) | 10% | $105,238 |
| 2021 | 240 | 129 | None | None | $15,524 |
| 2020 | 2,241 | 351 | 1% (18) | 12% | $127,680 |
| 2019 | 3,689 | 633 | 1% (31) | 13% | $240,111 |
| 2018 | 2,070 | 542 | None | 15% | $113,487 |
| 2017 | 1,187 | 337 | None | 14% | $67,969 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 58 drugs
| Eliquis | 34 | $33,737 | $992 |
| Ozempic | 18 | $22,391 | $1,244 |
| Trelegy Ellipta | 12 | $12,762 | $1,064 |
| Atorvastatin | 163 | $2,002 | $12 |
| Albuterol Sulfate Hfa | 37 | $1,972 | $53 |
| Levothyroxine | 122 | $1,852 | $15 |
| Ventolin Hfa | 13 | $1,786 | $137 |
| Losartan | 90 | $1,564 | $17 |
| Metoprolol | 62 | $1,147 | $18 |
| Omeprazole | 77 | $1,071 | $14 |
| Amlodipine Besylate | 104 | $910 | $9 |
| Ipratropium | 22 | $743 | $34 |
| Lisinopril | 96 | $739 | $8 |
| Estradiol | 16 | $676 | $42 |
| Rosuvastatin | 39 | $664 | $17 |
| Simvastatin | 58 | $641 | $11 |
| Sertraline | 30 | $593 | $20 |
| Celecoxib | 12 | $581 | $48 |
| Trazodone | 40 | $538 | $13 |
| Tamsulosin | 23 | $497 | $22 |
| Gabapentin | 44 | $482 | $11 |
| Valacyclovir | 12 | $403 | $34 |
| Allopurinol | 24 | $402 | $17 |
| Losartan-Hydrochlorothiazide | 21 | $400 | $19 |
| Zolpidem | 40 | $388 | $10 |
| Ondansetron | 13 | $356 | $27 |
| Duloxetine | 12 | $355 | $30 |
| Metformin Hcl Er | 20 | $347 | $17 |
| Metformin | 36 | $326 | $9 |
| Bupropion Xl | 11 | $312 | $28 |
| Alendronate | 24 | $286 | $12 |
| Pravastatin | 18 | $282 | $16 |
| Hydrochlorothiazide | 57 | $274 | $5 |
| Benazepril | 14 | $273 | $19 |
| Potassium Chloride | 13 | $270 | $21 |
| Montelukast | 12 | $267 | $22 |
| Nitrofurantoin Mono-Macro | 16 | $241 | $15 |
| Oxycodone-Acetaminophen | 11 | $228 | $21 |
| Methylprednisolone | 22 | $219 | $10 |
| Carvedilol | 13 | $217 | $17 |
| Pantoprazole | 13 | $205 | $16 |
| Sucralfate | 11 | $192 | $17 |
| Fluoxetine | 16 | $189 | $12 |
| Escitalopram | 12 | $188 | $16 |
| Spironolactone | 16 | $166 | $10 |
| Lovastatin | 13 | $162 | $12 |
| Fluticasone Propionate | 16 | $158 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $144 | $9 |
| Triamcinolone Acetonide | 20 | $134 | $7 |
| Citalopram Hbr | 17 | $116 | $7 |
| Furosemide | 15 | $103 | $7 |
| Metoprolol | 12 | $100 | $8 |
| Fluconazole | 13 | $100 | $8 |
| Azithromycin | 14 | $75 | $5 |
| Alprazolam | 16 | $70 | $4 |
| Meloxicam | 13 | $67 | $5 |
| Cyclobenzaprine | 14 | $64 | $5 |
| Promethazine | 12 | $21 | $2 |
2022: 42 drugs
| Eliquis | 18 | $18,434 | $1,024 |
| Albuterol Sulfate Hfa | 39 | $1,616 | $41 |
| Atorvastatin | 107 | $1,411 | $13 |
| Levothyroxine | 77 | $1,224 | $16 |
| Omeprazole | 74 | $836 | $11 |
| Potassium Chloride | 11 | $583 | $53 |
| Lisinopril | 69 | $568 | $8 |
| Oxycodone-Acetaminophen | 15 | $549 | $37 |
| Losartan | 43 | $525 | $12 |
| Metoprolol | 29 | $515 | $18 |
| Amlodipine Besylate | 48 | $452 | $9 |
| Tamsulosin | 19 | $416 | $22 |
| Sertraline | 36 | $409 | $11 |
| Estradiol | 12 | $385 | $32 |
| Metformin | 38 | $342 | $9 |
| Trazodone | 24 | $332 | $14 |
| Metformin Hcl Er | 24 | $323 | $13 |
| Pravastatin | 18 | $306 | $17 |
| Rosuvastatin | 19 | $301 | $16 |
| Zolpidem | 27 | $299 | $11 |
| Methylprednisolone | 32 | $298 | $9 |
| Nitrofurantoin Mono-Macro | 15 | $252 | $17 |
| Celecoxib | 15 | $233 | $16 |
| Cyclobenzaprine | 18 | $230 | $13 |
| Gabapentin | 25 | $205 | $8 |
| Simvastatin | 30 | $195 | $7 |
| Alendronate | 18 | $190 | $11 |
| Escitalopram | 11 | $174 | $16 |
| Clopidogrel | 11 | $174 | $16 |
| Doxycycline Hyclate | 15 | $158 | $11 |
| Allopurinol | 17 | $135 | $8 |
| Montelukast | 11 | $111 | $10 |
| Spironolactone | 11 | $110 | $10 |
| Hydrochlorothiazide | 42 | $107 | $3 |
| Meloxicam | 27 | $104 | $4 |
| Lisinopril-Hydrochlorothiazide | 13 | $100 | $8 |
| Amoxicillin-Clavulanate Potass | 15 | $86 | $6 |
| Azithromycin | 15 | $78 | $5 |
| Triamcinolone Acetonide | 12 | $68 | $6 |
| Fluoxetine | 16 | $65 | $4 |
| Clonazepam | 13 | $64 | $5 |
| Paxlovid (Eua) | 11 | $54 | $5 |
2021: 4 drugs
| Potassium Chloride | 14 | $212 | $15 |
| Levothyroxine | 11 | $146 | $13 |
| Lisinopril | 19 | $114 | $6 |
| Hydrochlorothiazide | 11 | $28 | $3 |
2020: 52 drugs
| Eliquis | 12 | $15,157 | $1,263 |
| Xarelto | 12 | $12,742 | $1,062 |
| Advair Diskus | 11 | $7,704 | $700 |
| Levothyroxine | 86 | $2,274 | $26 |
| Ventolin Hfa | 28 | $1,794 | $64 |
| Albuterol Sulfate Hfa | 27 | $1,749 | $65 |
| Atorvastatin | 93 | $1,663 | $18 |
| Omeprazole | 116 | $1,384 | $12 |
| Venlafaxine Hcl Er | 26 | $1,133 | $44 |
| Rosuvastatin | 28 | $1,088 | $39 |
| Metoprolol | 56 | $1,014 | $18 |
| Potassium Chloride | 47 | $961 | $20 |
| Lisinopril | 131 | $847 | $6 |
| Duloxetine | 40 | $816 | $20 |
| Amlodipine Besylate | 114 | $809 | $7 |
| Fluticasone Propionate | 46 | $749 | $16 |
| Pravastatin | 29 | $727 | $25 |
| Fluoxetine | 13 | $676 | $52 |
| Novotwist | 12 | $674 | $56 |
| Doxycycline Hyclate | 37 | $667 | $18 |
| Simvastatin | 65 | $651 | $10 |
| Losartan | 42 | $636 | $15 |
| Meloxicam | 63 | $465 | $7 |
| Glipizide Er | 24 | $420 | $17 |
| Cefdinir | 23 | $407 | $18 |
| Trazodone | 32 | $400 | $12 |
| Clopidogrel | 30 | $396 | $13 |
| Metformin | 45 | $375 | $8 |
| Ropinirole | 13 | $371 | $29 |
| Pantoprazole | 23 | $365 | $16 |
| Enalapril Maleate | 12 | $323 | $27 |
| Buspirone | 28 | $292 | $10 |
| Gabapentin | 22 | $284 | $13 |
| Sertraline | 26 | $280 | $11 |
| Triamcinolone Acetonide | 16 | $263 | $16 |
| Lisinopril-Hydrochlorothiazide | 24 | $250 | $10 |
| Diclofenac | 15 | $233 | $16 |
| Montelukast | 22 | $228 | $10 |
| Metformin Hcl Er | 29 | $207 | $7 |
| Metoprolol | 27 | $185 | $7 |
| Hydralazine | 12 | $167 | $14 |
| Allopurinol | 16 | $151 | $9 |
| Atenolol | 18 | $151 | $8 |
| Tizanidine | 12 | $144 | $12 |
| Furosemide | 28 | $144 | $5 |
| Hydrochlorothiazide | 33 | $141 | $4 |
| Glimepiride | 15 | $125 | $8 |
| Carvedilol | 17 | $123 | $7 |
| Prednisone | 30 | $117 | $4 |
| Meclizine | 11 | $112 | $10 |
| Tramadol | 18 | $95 | $5 |
| Zolpidem | 15 | $42 | $3 |
2019: 78 drugs
| Eliquis | 43 | $34,470 | $802 |
| Xarelto | 19 | $14,552 | $766 |
| Advair Diskus | 18 | $13,836 | $769 |
| Lantus Solostar | 12 | $8,510 | $709 |
| Symbicort | 11 | $6,913 | $628 |
| Ventolin Hfa | 49 | $3,563 | $73 |
| Levothyroxine | 126 | $3,146 | $25 |
| Omeprazole | 151 | $2,437 | $16 |
| Atorvastatin | 133 | $2,311 | $17 |
| Duloxetine | 58 | $2,096 | $36 |
| Lisinopril | 166 | $1,628 | $10 |
| Doxycycline Hyclate | 83 | $1,436 | $17 |
| Potassium Chloride | 49 | $1,399 | $29 |
| Metoprolol | 57 | $1,374 | $24 |
| Pravastatin | 44 | $1,368 | $31 |
| Rosuvastatin | 45 | $1,310 | $29 |
| Venlafaxine Hcl Er | 30 | $1,239 | $41 |
| Amlodipine Besylate | 137 | $1,203 | $9 |
| Simvastatin | 91 | $1,026 | $11 |
| Cefdinir | 49 | $981 | $20 |
| Sucralfate | 27 | $960 | $36 |
| Clopidogrel | 43 | $949 | $22 |
| Nadolol | 13 | $901 | $69 |
| Trazodone | 57 | $860 | $15 |
| Fluticasone Propionate | 56 | $809 | $14 |
| Enalapril Maleate | 23 | $801 | $35 |
| Meloxicam | 94 | $757 | $8 |
| Gabapentin | 56 | $721 | $13 |
| Diclofenac | 29 | $702 | $24 |
| Novotwist | 13 | $701 | $54 |
| Baclofen | 60 | $670 | $11 |
| Albuterol Sulfate Hfa | 12 | $655 | $55 |
| Metformin | 56 | $643 | $11 |
| Sertraline | 53 | $583 | $11 |
| Hydroxyzine | 23 | $583 | $25 |
| Losartan | 54 | $563 | $10 |
| Prednisone | 137 | $561 | $4 |
| Fluoxetine | 23 | $537 | $23 |
| Hydralazine | 22 | $520 | $24 |
| Ipratropium | 11 | $517 | $47 |
| Pantoprazole | 25 | $502 | $20 |
| Glipizide Er | 33 | $493 | $15 |
| Atenolol | 40 | $485 | $12 |
| Tramadol | 31 | $481 | $16 |
| Hydrochlorothiazide | 61 | $393 | $6 |
| Donepezil | 16 | $378 | $24 |
| Montelukast | 31 | $370 | $12 |
| Lisinopril-Hydrochlorothiazide | 36 | $357 | $10 |
| Spironolactone | 16 | $353 | $22 |
| Tamsulosin | 24 | $324 | $13 |
| Buspirone | 19 | $318 | $17 |
| Metoprolol | 36 | $317 | $9 |
| Ropinirole | 20 | $315 | $16 |
| Ranitidine | 32 | $306 | $10 |
| Citalopram Hbr | 27 | $305 | $11 |
| Nystatin | 15 | $305 | $20 |
| Meclizine | 23 | $300 | $13 |
| Allopurinol | 18 | $298 | $17 |
| Metformin Hcl Er | 30 | $290 | $10 |
| Clotrimazole-Betamethasone | 13 | $289 | $22 |
| Triamterene-Hydrochlorothiazid | 20 | $278 | $14 |
| Carvedilol | 26 | $272 | $10 |
| Tizanidine | 27 | $271 | $10 |
| Furosemide | 44 | $254 | $6 |
| Levocetirizine Dihydrochloride | 11 | $254 | $23 |
| Mupirocin | 30 | $249 | $8 |
| Doxazosin Mesylate | 12 | $241 | $20 |
| Isosorbide Mononitrate Er | 11 | $215 | $20 |
| Azithromycin | 26 | $196 | $8 |
| Triamcinolone Acetonide | 21 | $184 | $9 |
| Ibuprofen | 13 | $177 | $14 |
| Cyclobenzaprine | 16 | $167 | $10 |
| Glimepiride | 15 | $156 | $10 |
| Clindamycin | 14 | $143 | $10 |
| Amoxicillin | 35 | $134 | $4 |
| Fluconazole | 14 | $121 | $9 |
| Ondansetron | 12 | $109 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $102 | $9 |
2018: 51 drugs
| Levemir Flextouch | 14 | $13,265 | $948 |
| Breo Ellipta | 12 | $8,303 | $692 |
| Tradjenta | 11 | $5,786 | $526 |
| Doxycycline Hyclate | 119 | $2,309 | $19 |
| Levothyroxine | 70 | $1,666 | $24 |
| Ventolin Hfa | 26 | $1,637 | $63 |
| Metoprolol | 32 | $1,386 | $43 |
| Memantine | 17 | $1,361 | $80 |
| Omeprazole | 69 | $995 | $14 |
| Atorvastatin | 75 | $942 | $13 |
| Rosuvastatin | 29 | $848 | $29 |
| Potassium Chloride | 24 | $813 | $34 |
| Pravastatin | 26 | $685 | $26 |
| Novotwist | 13 | $648 | $50 |
| Amlodipine Besylate | 58 | $635 | $11 |
| Fluticasone Propionate | 58 | $618 | $11 |
| Lisinopril | 69 | $564 | $8 |
| Prednisone | 116 | $522 | $5 |
| Cefdinir | 24 | $509 | $21 |
| Carbamazepine Er | 12 | $504 | $42 |
| Duloxetine | 17 | $497 | $29 |
| Gabapentin | 30 | $466 | $16 |
| Montelukast | 20 | $397 | $20 |
| Venlafaxine Hcl Er | 16 | $386 | $24 |
| Tamsulosin | 31 | $350 | $11 |
| Sucralfate | 11 | $348 | $32 |
| Glipizide Er | 12 | $337 | $28 |
| Sertraline | 33 | $337 | $10 |
| Simvastatin | 39 | $335 | $9 |
| Metoprolol | 34 | $284 | $8 |
| Pantoprazole | 12 | $284 | $24 |
| Nitrofurantoin Mono-Macro | 12 | $276 | $23 |
| Ranitidine | 20 | $263 | $13 |
| Atenolol | 20 | $248 | $12 |
| Amoxicillin | 40 | $241 | $6 |
| Losartan | 23 | $218 | $9 |
| Metformin | 29 | $211 | $7 |
| Triamcinolone Acetonide | 24 | $209 | $9 |
| Mupirocin | 22 | $203 | $9 |
| Hydroxyzine | 13 | $198 | $15 |
| Furosemide | 35 | $193 | $6 |
| Baclofen | 29 | $187 | $6 |
| Azithromycin | 24 | $179 | $7 |
| Losartan-Hydrochlorothiazide | 13 | $156 | $12 |
| Ondansetron Odt | 13 | $153 | $12 |
| Meclizine | 14 | $145 | $10 |
| Meloxicam | 30 | $125 | $4 |
| Carvedilol | 22 | $122 | $6 |
| Hydrochlorothiazide | 24 | $109 | $5 |
| Benazepril | 11 | $92 | $8 |
| Ciprofloxacin | 18 | $90 | $5 |
2017: 31 drugs
| Eliquis | 14 | $8,535 | $610 |
| Doxycycline Hyclate | 62 | $1,188 | $19 |
| Ventolin Hfa | 13 | $692 | $53 |
| Levothyroxine | 22 | $662 | $30 |
| Atorvastatin | 29 | $651 | $22 |
| Gabapentin | 37 | $535 | $14 |
| Fluticasone Propionate | 41 | $424 | $10 |
| Venlafaxine Hcl Er | 20 | $411 | $21 |
| Amlodipine Besylate | 41 | $408 | $10 |
| Metoprolol | 13 | $368 | $28 |
| Lisinopril | 45 | $328 | $7 |
| Mupirocin | 20 | $305 | $15 |
| Simvastatin | 25 | $301 | $12 |
| Rosuvastatin | 14 | $283 | $20 |
| Omeprazole | 22 | $250 | $11 |
| Azithromycin | 29 | $230 | $8 |
| Amoxicillin-Clavulanate Potass | 19 | $225 | $12 |
| Prednisone | 48 | $218 | $5 |
| Metoprolol | 26 | $194 | $7 |
| Tamsulosin | 13 | $175 | $13 |
| Pantoprazole | 17 | $169 | $10 |
| Hydrochlorothiazide | 22 | $160 | $7 |
| Losartan-Hydrochlorothiazide | 17 | $139 | $8 |
| Baclofen | 15 | $132 | $9 |
| Clindamycin | 11 | $130 | $12 |
| Metformin | 17 | $115 | $7 |
| Furosemide | 14 | $100 | $7 |
| Citalopram Hbr | 12 | $100 | $8 |
| Ciprofloxacin | 16 | $70 | $4 |
| Sulfamethoxazole-Trimethoprim | 14 | $59 | $4 |
| Cephalexin | 11 | $40 | $4 |
Money from drug and device companies
$13 in 2024
| 2024 | 1 | 1 | None | $13 |
| 2022 | 1 | 1 | None | $15 |
| 2021 | 1 | 5 | None | $89 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $13 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2024-06-17 | Ozempic | $13 |
See earlier years (2022, 2021)
2022: $15
| Kowa Pharmaceuticals America | Seglentis | $15 | 1 payment
|
2021: $89
| AbbVie | Ubrelvy | $89 | 5 payments
|
Professional record
- NPI
- 1376081661
- Licence
- CA PA57948, NV PA2450
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 1155 Mill St, Ms M-14, Reno, NV, 89502
- NPI first listed
- 2017-02-07
- NPI last updated
- 2025-06-16
- NPI record certified
- 2025-06-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 803 Eleventh Ave, Sunnyvale, CA, 94089